Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter T Chapman

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Drugs & Aging|September 27, 2014
Urate-lowering therapy: current options and future prospects for elderly patients with goutLisa K Stamp, Peter T Chapman
Best Practice & Research. Clinical Rheumatology|April 9, 2020
Allopurinol hypersensitivity: Pathogenesis and preventionLisa K Stamp, Peter T Chapman
Current Rheumatology Reports|January 20, 2012
Gout and organ transplantationLisa K Stamp, Peter T Chapman
Rheumatology (Oxford, England)|September 6, 2012
Gout and its comorbidities: implications for therapyLisa K Stamp, Peter T Chapman
Pain Medicine (Malden, Mass.)|September 16, 2004
Efficacy of pamidronate in complex regional pain syndrome type IJohn N Robinson, Jenny Sandom, Peter T Chapman
Joint Bone Spine|October 11, 2015
Allopurinol and kidney function: An updateLisa K Stamp, Peter T Chapman, Suetonia C Palmer
The Journal of Rheumatology|April 3, 2015
Patient Information about Gout: An International Review of Existing Educational ResourcesMegan E Johnston, Gareth J Treharne, Peter T Chapman, et al.
Internal Medicine Journal|November 15, 2018
Serum urate levels and therapy in adults treated with long-term dialysis: a retrospective cross-sectional studyEstella Yeo, Suetonia C Palmer, Peter T Chapman, et al.
International Journal of Rheumatic Diseases|February 28, 2013
Cardiovascular morbidity in rheumatoid arthritis patients in North Canterbury, New Zealand 1999-2008Emon A R Khan, Lisa K Stamp, John L O'Donnell, et al.
The Journal of Rheumatology|October 17, 2007
Leflunomide-associated infections in rheumatoid arthritisKatey A Jenks, Lisa K Stamp, John L O'Donnell, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Drugs & Aging|September 27, 2014
Urate-lowering therapy: current options and future prospects for elderly patients with goutLisa K Stamp, Peter T Chapman
Best Practice & Research. Clinical Rheumatology|April 9, 2020
Allopurinol hypersensitivity: Pathogenesis and preventionLisa K Stamp, Peter T Chapman
Current Rheumatology Reports|January 20, 2012
Gout and organ transplantationLisa K Stamp, Peter T Chapman
Rheumatology (Oxford, England)|September 6, 2012
Gout and its comorbidities: implications for therapyLisa K Stamp, Peter T Chapman
Pain Medicine (Malden, Mass.)|September 16, 2004
Efficacy of pamidronate in complex regional pain syndrome type IJohn N Robinson, Jenny Sandom, Peter T Chapman
Joint Bone Spine|October 11, 2015
Allopurinol and kidney function: An updateLisa K Stamp, Peter T Chapman, Suetonia C Palmer
The Journal of Rheumatology|April 3, 2015
Patient Information about Gout: An International Review of Existing Educational ResourcesMegan E Johnston, Gareth J Treharne, Peter T Chapman, et al.
Internal Medicine Journal|November 15, 2018
Serum urate levels and therapy in adults treated with long-term dialysis: a retrospective cross-sectional studyEstella Yeo, Suetonia C Palmer, Peter T Chapman, et al.
International Journal of Rheumatic Diseases|February 28, 2013
Cardiovascular morbidity in rheumatoid arthritis patients in North Canterbury, New Zealand 1999-2008Emon A R Khan, Lisa K Stamp, John L O'Donnell, et al.
The Journal of Rheumatology|October 17, 2007
Leflunomide-associated infections in rheumatoid arthritisKatey A Jenks, Lisa K Stamp, John L O'Donnell, et al.
Pageof 4